Drug Company Gives Approval

Published: Wednesday, 08/22/2007 12:00 am EDT

Drug company GlaxoSmithKline Inc. will allow generic company Apotex Inc. to manufacture an antiretroviral drug that will be made available to Rwanda through Canada's Access to Medicines Regime, the company said last week. Apotex still needs consent from at least one other company for its three-in-one medication. So far, no pills have been distributed to Africa under the regime.

If you are already a subscriber

Subscribe to Embassy

Subscribe to the print and electronic editions and get instant access to Embassy online.

Quick purchase

Purchase this week's edition of Embassy in electronic format (PDF) for $4.00

Sign up for a free trial

For access to the website.

This Week's Issue
policy briefings